A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride
![Thumbnail](/xmlui/bitstream/handle/11491/1919/%28Asafov%29%20Yazla%2c%20Ece.pdf.jpg?sequence=11&isAllowed=y)
View/ Open
Access
info:eu-repo/semantics/openAccessAttribution 4.0 International (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/Date
2018Metadata
Show full item recordCitation
Karayağmurlu, A., Karayağmurlu, E., Üstündağ, M. F., Yazla, E. (2018). A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride. Electronic Journal of General Medicine, 15(3).Abstract
Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome (NMS). This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature. © 2018 by the authors; licensee Modestum Ltd., UK.
Source
Electronic Journal of General MedicineVolume
15Issue
3Collections
- Makale Koleksiyonu [515]
- Scopus İndeksli Yayınlar Koleksiyonu [2683]
- WoS İndeksli Yayınlar Koleksiyonu [2971]